{
    "nctId": "NCT01780532",
    "briefTitle": "Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study",
    "officialTitle": "Pilot Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "The lesion visibility on PAI, described using a five-level scale: 1. Not visible 2. Barely visible 3. Fair (or moderately visible) 4. Visible 5. Clearly visible.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients must have a breast lesion/mass found at physical examination, mammography or ultrasound (US), that has not been surgically resected\n* Patients may have any of the following characteristics:\n\n  * Taking hormones (e.g., contraceptives, hormone replacement therapy, post-cancer Tamoxifen)\n  * Breast implants\n  * Previous breast biopsy\n  * Previous breast surgery\n  * Previous breast cancer\n  * High risk of breast cancer (e.g., breast cancer susceptibility gene (BRCA) mutations, other gynecologic cancer)\n* Ability to understand and the willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Patients who have had primary surgical excision of the suspicious finding\n* Pregnant or lactating women",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}